The Prognostic Value of Early Detection of Minimal Residual Disease As Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients after Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation.
Frontiers in oncology（2021）
Key words
myelodysplastic syndromes (MDS),allogeneic hematopoietic stem cell transplantation (AHSCT),minimal residual disease (MRD),multiparameter flow cytometry (MFC),gene mutation clearance
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined